PATENT CLAIM ANALYSIS

Application Number: 16122050
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-02
Patent Classification: ["435", "122000"]

Abstract:
Methods that may be used for the manufacture of the chemical compound (S)-norcoclaurine, (S)-norlaudanosoline, and (S)-norcoclaurine or (S)-norlaudanosoline synthesis intermediates are provided. (S)-Norcoclaurine, (S)-norlaudanosoline, and (S)-norcoclaurine or (S)-norlaudanosoline synthesis intermediates are useful as precursor products in the manufacture of certain medicinal agents.

Claim (Index 17):
The host cell according to  claim 15  comprising a chimeric nucleic acid sequence comprising a promoter capable of controlling expression in a host cell linked to a nucleic acid sequence encoding norcoclaurine synthase (NCS), wherein the host cell is able to produce at least one of L-tyrosine, L-DOPA, dopamine, tyramine, 4-hydroxy-phenylacetaldehyde (4-HPAA), and 3,4-dihydroxy-phenylacetaldehyde (3,4-DHPAA), and wherein the host cell is unable to produce (S)-norcoclaurine or (S)-norlaudanosoline, but for the presence of the chimeric nucleic acid sequence.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 97.0
- Lexical Diversity: 2.18182
- Patent Class: 435.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15319568', '15031618', '15507711', '12664142', '11875814']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.663060468150945
- 35 USC 102 Novelty (BERT): 0.6414450385888658
- Combined Prediction Score: 0.6608989251947371
- Mean Citation Score: 506.53779200000014
- Max Citation Score: 884.3435699999999
- Similarity Product: 568.7657003832061

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test